Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03534258 · ClinicalTrials.gov registry record
Does Use of Rapid Response EEG Impact Clinical Decision Making
A clinical trial, sponsored by Ceribell.
- Completed
- Registry status
- 164
- Enrollment target
NCT03534258: Completed study, sponsored by Ceribell.
NCT03534258 is a clinical trial that has completed, run by Ceribell. The registered enrollment target is 164 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03534258 has completed, sponsored by Ceribell.
- COMPLETED
- Registry status
- 164 participants
- Enrollment target
Study Summary
This study is designed as a prospective, non-randomized, observational, multicenter clinical trial. The primary aim of this study is to observe if the use of the rapid responds electroencephalography (EEG) system impacts physician decision making. Secondary aims include exploring the safety and performance information of the Ceribell EEG system compared to conventional EEG system. The study will recruit physicians (Faculty physicians and Trainees) at up to five institutions and examine the impact of rapid response EEG when providing care to patients in whom EEG recording has been ordered for clinical reasons.
Primary Outcome
Physician will record their diagnostic assessment of seizure in Yes or No.
Interventions
- DEVICE Ceribell Rapid Response EEG, Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2018-04-30 |
| Est. Completion | 2019-07-31 |
What the finished NCT03534258 record still lists
NCT03534258 is an observational study that tracks outcomes without assigning an intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Ceribell Rapid Response EEG, Survey is the first listed.
NCT03534258 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03534258 about?
NCT03534258 is a clinical study titled "Does Use of Rapid Response EEG Impact Clinical Decision Making". This study is designed as a prospective, non-randomized, observational, multicenter clinical trial. The primary aim of this study is to observe if the use of the rapid responds electroencephalography (EEG) system impacts physician decision making. Secondary aims include exploring the safety and perf...
What is the current status of trial NCT03534258?
This trial is currently completed. The enrollment target is 164 participants. The study started on 2018-04-30. Estimated completion is 2019-07-31.
What interventions are being tested in trial NCT03534258?
The interventions under investigation include: Ceribell Rapid Response EEG, Survey (DEVICE).
Who is sponsoring clinical trial NCT03534258?
This trial is sponsored by Ceribell, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI